Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > CopyTele Licenses Technology to AUO For E-Paper® and Nano Displays

Abstract:
CopyTele, Inc. (OTCBB:COPY) announced today that it has entered into two license agreements with AU Optronics Corp. ("AUO") (NYSE:AUO) of Hsinchu, Taiwan to produce and market CopyTele's E-Paper® and Nano Display technologies. The license agreements grant AUO an exclusive license for CopyTele's E-Paper® display patents and technology with the right to sublicense the technology to third parties and a non-exclusive license for CopyTele's Nano Display patents and technology with the right to consent to the granting of licenses of the Nano Display technology to third parties. Under the agreements, AUO will pay CopyTele aggregate license fees of US $10 million, $3 million payable as an initial fee and $7 million upon completion of certain conditions for the respective technologies. The terms of the agreements provide for the basis for royalty payments by AUO to CopyTele.

CopyTele Licenses Technology to AUO For E-Paper® and Nano Displays

Melville, NY | Posted on June 1st, 2011

Our advanced E-Paper® electrophoretic display technology utilizes specially coated particles in combination with a unique type of pixel structure to create an image. This new technology is applicable for electronic books and other low power applications. Our Nano display technology incorporates a new type of low voltage color phosphors in combination with nano materials and an electron emission system utilizing nano materials to produce color video information. CopyTele's Nano Display is applicable to small hand-held and larger size applications including TV's.

CopyTele Chairman and CEO, Denis A. Krusos, said, "We are pleased to have an agreement with AUO, one of the world's leaders in flat panel displays. With the addition of AUO, CopyTele has the opportunity to bring its display technologies into all phases of the world-wide display marketplace."

AUO is a global leader of thin film transistor liquid crystal display panels (TFT-LCD). AUO is able to provide customers with a full range of panel sizes and comprehensive applications, offering TFT-LCD panels in sizes ranging from 1.2 inches to greater than 71 inches. AUO generated NT $467.2 billion in sales revenue in 2010 (US $16 billion*) with global operations in Taiwan, Mainland China, Japan, Singapore, South Korea, the U.S., and Europe. Additionally, AUO is the first pure TFT-LCD manufacturer to be successfully listed at the New York Stock Exchange (NYSE). AUO extended its market to the green energy industry in late 2008. The Display and Solar businesses were established respectively as the Company's two core businesses in October, 2010. For more information, please visit AUO.com.

*2010 year end revenue converted at an exchange rate of NTD29.14:USD1.

####

About CopyTele, Inc.
CopyTele’s principal operations include the development, production and marketing of thin flat display technologies, including low-voltage phosphor color displays and low-power passive E-Paper® displays, and the development, production and marketing of multi-functional encryption products that provide information security for domestic and international users over virtually every communications media. For more information on CopyTele, please visit CopyTele.com.

Forward-Looking Statements:

Statements that are not historical fact may be considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical facts, but rather reflect CopyTele’s current expectations concerning future events and results. CopyTele generally uses the words “believes”, “expects”, “intends”, “plans”, “anticipates”, “likely”, “will” and similar expressions to identify forward-looking statements. Such forward-looking statements, including those concerning CopyTele’s expectations, involve known and unknown risks, uncertainties and other factors, some of which are beyond CopyTele’s control, which may cause CopyTele’s actual results, performance or achievements, or industry results, to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. In evaluating such statements as well as the future prospects of CopyTele, specific consideration should be given to various factors, including the following: CopyTele’s prior history of losses and negative cash flows from operations; CopyTele’s ability to obtain debt or equity financing to continue our marketing, research and development activities, on terms acceptable to CopyTele, if cash generated from operations is insufficient to satisfy our liquidity requirements; CopyTele’s ability to commercialize a full-color video display; the possible development of competitive products that could render CopyTele’s products obsolete or unmarketable; and other risks as detailed from time-to-time in CopyTele’s filings with the Securities and Exchange Commission. CopyTele undertakes no obligation to update any forward-looking statements as a result of new information, unanticipated events, or otherwise.

For more information, please click here

Contacts:
CopyTele, Inc.
Anne Rotondo
631-549-5900

Copyright © Business Wire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Researchers develop artificial building blocks of life March 8th, 2024

How surface roughness influences the adhesion of soft materials: Research team discovers universal mechanism that leads to adhesion hysteresis in soft materials March 8th, 2024

Two-dimensional bimetallic selenium-containing metal-organic frameworks and their calcinated derivatives as electrocatalysts for overall water splitting March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

Display technology/LEDs/SS Lighting/OLEDs

Light guide plate based on perovskite nanocomposites November 3rd, 2023

Simple ballpoint pen can write custom LEDs August 11th, 2023

Novel design perovskite electrochemical cell for light-emission and light-detection May 12th, 2023

A universal HCl-assistant powder-to-powder strategy for preparing lead-free perovskites March 24th, 2023

Nanoelectronics

Interdisciplinary: Rice team tackles the future of semiconductors Multiferroics could be the key to ultralow-energy computing October 6th, 2023

Key element for a scalable quantum computer: Physicists from Forschungszentrum Jülich and RWTH Aachen University demonstrate electron transport on a quantum chip September 23rd, 2022

Reduced power consumption in semiconductor devices September 23rd, 2022

Atomic level deposition to extend Moore’s law and beyond July 15th, 2022

Announcements

What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

The Access to Advanced Health Institute receives up to $12.7 million to develop novel nanoalum adjuvant formulation for better protection against tuberculosis and pandemic influenza March 8th, 2024

Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024

Patents/IP/Tech Transfer/Licensing

Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023

Study finds nanomedicine targeting lymph nodes key to triple negative breast cancer treatment: In mice, nanomedicine can remodel the immune microenvironment in lymph node and tumor tissue for long-term remission and lung tumor elimination in this form of metastasized breast cance May 13th, 2022

Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021

Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project